|
1
|
miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors.
|
Mol Cell
|
2010
|
3.27
|
|
2
|
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.
|
Blood
|
2012
|
2.91
|
|
3
|
Chromosomal translocations induced at specified loci in human stem cells.
|
Proc Natl Acad Sci U S A
|
2009
|
2.73
|
|
4
|
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.
|
Proc Natl Acad Sci U S A
|
2009
|
2.54
|
|
5
|
A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication.
|
Mol Cell
|
2008
|
2.28
|
|
6
|
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
|
Blood
|
2013
|
2.14
|
|
7
|
Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype.
|
Dev Cell
|
2009
|
2.12
|
|
8
|
Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient.
|
N Engl J Med
|
2003
|
2.09
|
|
9
|
The p400 ATPase regulates nucleosome stability and chromatin ubiquitination during DNA repair.
|
J Cell Biol
|
2010
|
1.80
|
|
10
|
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition.
|
J Exp Med
|
2012
|
1.65
|
|
11
|
Radiation injury after a nuclear detonation: medical consequences and the need for scarce resources allocation.
|
Disaster Med Public Health Prep
|
2011
|
1.60
|
|
12
|
The evolution of influenza resistance and treatment.
|
JAMA
|
2009
|
1.40
|
|
13
|
Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry.
|
PLoS One
|
2013
|
1.32
|
|
14
|
Adamantane resistance in influenza A.
|
JAMA
|
2006
|
1.25
|
|
15
|
BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair.
|
Blood
|
2009
|
1.13
|
|
16
|
TSLP signaling network revealed by SILAC-based phosphoproteomics.
|
Mol Cell Proteomics
|
2012
|
1.04
|
|
17
|
Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S./European Consultation Workshop.
|
Stem Cells
|
2009
|
1.03
|
|
18
|
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation.
|
Cancer Discov
|
2011
|
1.02
|
|
19
|
Allocation of scarce resources after a nuclear detonation: setting the context.
|
Disaster Med Public Health Prep
|
2011
|
0.99
|
|
20
|
Inactivation of Uaf1 causes defective homologous recombination and early embryonic lethality in mice.
|
Mol Cell Biol
|
2013
|
0.98
|
|
21
|
Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2.
|
Blood
|
2012
|
0.97
|
|
22
|
PARP1 is required for chromosomal translocations.
|
Blood
|
2013
|
0.96
|
|
23
|
TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling.
|
Database (Oxford)
|
2014
|
0.93
|
|
24
|
The evolving contribution of hematopoietic progenitor cells to lymphomagenesis.
|
Blood
|
2012
|
0.92
|
|
25
|
Repair at single targeted DNA double-strand breaks in pluripotent and differentiated human cells.
|
PLoS One
|
2011
|
0.91
|
|
26
|
Triage and treatment tools for use in a scarce resources-crisis standards of care setting after a nuclear detonation.
|
Disaster Med Public Health Prep
|
2011
|
0.89
|
|
27
|
t(X;14)(p22;q32)/t(Y;14)(p11;q32) CRLF2-IGH translocations from human B-lineage ALLs involve CpG-type breaks at CRLF2, but CRLF2/P2RY8 intrachromosomal deletions do not.
|
Blood
|
2010
|
0.88
|
|
28
|
Medical planning and response for a nuclear detonation: a practical guide.
|
Biosecur Bioterror
|
2012
|
0.87
|
|
29
|
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.
|
Cancer Cell
|
2016
|
0.87
|
|
30
|
Scarce resources for nuclear detonation: project overview and challenges.
|
Disaster Med Public Health Prep
|
2011
|
0.86
|
|
31
|
The transposase domain protein Metnase/SETMAR suppresses chromosomal translocations.
|
Cancer Genet Cytogenet
|
2010
|
0.86
|
|
32
|
Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors.
|
Biol Blood Marrow Transplant
|
2008
|
0.86
|
|
33
|
BCL2 suppresses PARP1 function and nonapoptotic cell death.
|
Cancer Res
|
2012
|
0.86
|
|
34
|
Medical response to a nuclear detonation: creating a playbook for state and local planners and responders.
|
Disaster Med Public Health Prep
|
2011
|
0.85
|
|
35
|
Medical management of radiation victims in the United States.
|
Health Phys
|
2010
|
0.80
|
|
36
|
Next-generation cDNA screening for oncogene and resistance phenotypes.
|
PLoS One
|
2012
|
0.80
|
|
37
|
Nosocomial central venous catheter infections among patients with different types of cancer.
|
Infect Control Hosp Epidemiol
|
2002
|
0.79
|
|
38
|
Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents.
|
Expert Rev Anti Infect Ther
|
2006
|
0.79
|
|
39
|
Assessing surge capacity for radiation victims with marrow toxicity.
|
Biol Blood Marrow Transplant
|
2010
|
0.79
|
|
40
|
Using the model of resource and time-based triage (MORTT) to guide scarce resource allocation in the aftermath of a nuclear detonation.
|
Disaster Med Public Health Prep
|
2011
|
0.79
|
|
41
|
Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemia.
|
Br J Haematol
|
2014
|
0.78
|
|
42
|
Public health and medical preparedness for a nuclear detonation: the nuclear incident medical enterprise.
|
Health Phys
|
2015
|
0.78
|
|
43
|
Health care system planning for and response to a nuclear detonation.
|
Disaster Med Public Health Prep
|
2011
|
0.77
|
|
44
|
Hepatitis C virus infection does not preclude standard breast cancer-directed therapy.
|
Clin Breast Cancer
|
2009
|
0.77
|
|
45
|
Postexposure prophylaxis against varicella zoster virus infection among hematopoietic stem cell transplant recipients.
|
Biol Blood Marrow Transplant
|
2006
|
0.76
|
|
46
|
Impact of the p53 status of tumor cells on extrinsic and intrinsic apoptosis signaling.
|
Cell Commun Signal
|
2013
|
0.75
|
|
47
|
Resource allocation after a nuclear detonation incident: unaltered standards of ethical decision making.
|
Disaster Med Public Health Prep
|
2011
|
0.75
|
|
48
|
New agents for the prevention of opportunistic infections in haematopoietic stem cell transplant recipients.
|
Expert Opin Pharmacother
|
2005
|
0.75
|
|
49
|
Corrigendum: PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA.
|
Nat Commun
|
2017
|
0.75
|